Atsushi Ikeda

628 citations
70 papers · 389 indexed · h-index 10
Topics
Bladder and Urothelial Cancer Treatments (21 papers)Urinary and Genital Oncology Studies (15 papers)Renal cell carcinoma treatment (5 papers)
Partner nations
JapanUnited StatesSweden

In The Last Decade

Atsushi Ikeda

54 papers receiving 381 citations

Peers

Atsushi Ikeda
Comparison fields: 5 of 80
  • Surgery 179
  • Pulmonary and Respiratory Medicine 73
  • Atmospheric Science 71
  • Oncology 66
  • Radiology, Nuclear Medicine and Imaging 45
Replace Marco Chiarelli with:
Marco Chiarelli Italy
M. Schrader Germany
Yuichi Nagata Japan
J. Ferrière France
Khaled Abdelwahab Egypt
David Stenger Germany
A. Bertaccini Italy
Satona Tanaka Japan
Atsushi Ikeda relative to Marco Chiarelli Italy Marco Chiarelli's profile →
Citations per field
00.5×5.5×
Marco Chiarelli · 1×
Citations per year

Countries citing papers authored by Atsushi Ikeda

Since Specialization
Citations

This map shows the geographic impact of Atsushi Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsushi Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsushi Ikeda more than expected).

Fields of papers citing papers by Atsushi Ikeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsushi Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsushi Ikeda. The network helps show where Atsushi Ikeda may publish in the future.

Co-authorship network of co-authors of Atsushi Ikeda

This figure shows the co-authorship network connecting the top 25 collaborators of Atsushi Ikeda. A scholar is included among the top collaborators of Atsushi Ikeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsushi Ikeda. Atsushi Ikeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 2
4 0
5 0
6 1
7 5
8 3
9 0
10 0
11 5
12 26
13 78
14 10
15 0
16 0
17 3
18 1
19 0
20 5

About Atsushi Ikeda

Atsushi Ikeda is a scholar working on Urology, Surgery and Rheumatology, having authored 70 papers that have together received 389 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (21 papers), Urinary and Genital Oncology Studies (15 papers) and Renal cell carcinoma treatment (5 papers). The work is most often cited by research in Health Informatics (13 citations), Urology (28 citations) and Surgery (179 citations). Atsushi Ikeda has collaborated with scholars based in Japan, United States and Sweden. Frequent co-authors include Norikazu Matsuoka, Hiroyuki Nishiyama, Takahiro Kojima, Hirokazu Nosato, Koji Kawai, Masahiro Murakawa, Hidenori Sakanashi, Hiromitsu Negoro, Shuya Kandori and Tomokazu Kimura. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026